SONN Annual SG&A
$6.13 M
-$994.90 K-13.96%
30 September 2024
Summary:
As of January 23, 2025, SONN annual selling, general & administrative expenses is $6.13 million, with the most recent change of -$994.90 thousand (-13.96%) on September 30, 2024. During the last 3 years, it has fallen by -$2.81 million (-31.40%). SONN annual SG&A is now -31.40% below its all-time high of $8.94 million, reached on September 30, 2021.SONN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN Quarterly SG&A
$1.97 M
+$172.90 K+9.60%
30 September 2024
Summary:
As of January 23, 2025, SONN quarterly selling, general & administrative expenses is $1.97 million, with the most recent change of +$172.90 thousand (+9.60%) on September 30, 2024. Over the past year, it has increased by +$172.90 thousand (+9.60%). SONN quarterly SG&A is now -28.98% below its all-time high of $2.78 million, reached on September 30, 2020.SONN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN TTM SG&A
-$454.69 M
-$7.44 M-1.66%
30 September 2024
Summary:
As of January 23, 2025, SONN TTM selling, general & administrative expenses is -$454.69 million, with the most recent change of -$7.44 million (-1.66%) on September 30, 2024. Over the past year, it has dropped by -$460.64 million (-7740.35%). SONN TTM SG&A is now -487.89% below its all-time high of $9.46 million, reached on March 31, 2021.SONN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.0% | +9.6% | -7740.4% |
| 3 y3 years | -31.4% | +9.6% | -7740.4% |
| 5 y5 years | +144.3% | +9.6% | -7740.4% |
SONN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | at low | -14.7% | +202.1% | -95.2% | at low |
| 5 y | 5-year | -31.4% | +144.3% | -29.0% | +202.1% | -487.9% | at low |
| alltime | all time | -31.4% | +144.3% | -29.0% | +202.1% | -487.9% | at low |
Sonnet BioTherapeutics Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $6.13 M(-14.0%) | $1.97 M(+9.6%) | $6.13 M(+3.0%) |
| June 2024 | - | $1.80 M(+5.9%) | $5.95 M(+4.5%) |
| Mar 2024 | - | $1.70 M(+160.3%) | $5.69 M(-3.1%) |
| Dec 2023 | - | $653.50 K(-63.6%) | $5.88 M(-17.5%) |
| Sept 2023 | $7.13 M(-16.9%) | $1.79 M(+16.3%) | $7.13 M(-6.8%) |
| June 2023 | - | $1.54 M(-18.1%) | $7.65 M(-8.8%) |
| Mar 2023 | - | $1.88 M(-1.0%) | $8.38 M(-0.2%) |
| Dec 2022 | - | $1.90 M(-17.8%) | $8.40 M(-2.0%) |
| Sept 2022 | $8.58 M | $2.32 M(+1.6%) | $8.58 M(-0.9%) |
| June 2022 | - | $2.28 M(+20.0%) | $8.65 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.90 M(-8.6%) | $8.73 M(-3.3%) |
| Dec 2021 | - | $2.08 M(-13.2%) | $9.02 M(+0.9%) |
| Sept 2021 | $8.94 M(+18.6%) | $2.39 M(+1.8%) | $8.94 M(-4.1%) |
| June 2021 | - | $2.35 M(+7.1%) | $9.33 M(-1.4%) |
| Mar 2021 | - | $2.20 M(+9.9%) | $9.46 M(+12.1%) |
| Dec 2020 | - | $2.00 M(-28.1%) | $8.44 M(+31.0%) |
| Sept 2020 | $7.53 M(+200.3%) | $2.78 M(+11.9%) | $6.44 M(+76.0%) |
| June 2020 | - | $2.48 M(+111.4%) | $3.66 M(+211.4%) |
| Mar 2020 | - | $1.18 M | $1.18 M |
| Sept 2019 | $2.51 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual SG&A year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly SG&A year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM SG&A year-on-year change?
What is Sonnet BioTherapeutics Holdings annual selling, general & administrative expenses?
The current annual SG&A of SONN is $6.13 M
What is the all time high annual SG&A for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual selling, general & administrative expenses is $8.94 M
What is Sonnet BioTherapeutics Holdings annual SG&A year-on-year change?
Over the past year, SONN annual selling, general & administrative expenses has changed by -$994.90 K (-13.96%)
What is Sonnet BioTherapeutics Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of SONN is $1.97 M
What is the all time high quarterly SG&A for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly selling, general & administrative expenses is $2.78 M
What is Sonnet BioTherapeutics Holdings quarterly SG&A year-on-year change?
Over the past year, SONN quarterly selling, general & administrative expenses has changed by +$172.90 K (+9.60%)
What is Sonnet BioTherapeutics Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of SONN is -$454.69 M
What is the all time high TTM SG&A for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM selling, general & administrative expenses is $9.46 M
What is Sonnet BioTherapeutics Holdings TTM SG&A year-on-year change?
Over the past year, SONN TTM selling, general & administrative expenses has changed by -$460.64 M (-7740.35%)